Prescription use disorders in older adults.
The number of older adults needing substance abuse treatment is projected to rise significantly in the next few decades. This paper will focus on the epidemic of prescription use disorders in older adults. Particular vulnerabilities of older adults to addiction will be considered. Specifically, the prevalence and patterns of use of opioids, stimulants, and benzodiazepines will be explored, including the effects of these substances on morbidity and mortality. Treatment intervention strategies will be briefly discussed, and areas for future research are suggested.
Department of Psychiatry, Division on Substance Abuse, New York State Psychiatric Institute, Columbia University, New York, New York 10032, USA. kalapat@pi.cpmc.columbia.edu
Raj K
RK
Kalapatapu
Maria A
MA
Sullivan
D000328:Adult; D000367:Age Factors; D000368:Aged; D000701:Analgesics, Opioid / Q000009:adverse effects; D001569:Benzodiazepines / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D055553:Prescription Drugs / Q000009:adverse effects*; D015995:Prevalence; D019966:Substance-Related Disorders / Q000453:epidemiology* / Q000401:mortality / Q000628:therapy
D000701:Analgesics, Opioid; D000697:Central Nervous System Stimulants; D055553:Prescription Drugs; D001569:Benzodiazepines